Matches in Wikidata for { <http://www.wikidata.org/entity/Q69936626> ?p ?o ?g. }
Showing items 1 to 66 of
66
with 100 items per page.
- Q69936626 description "artikull shkencor i botuar më 01 janar 1985" @default.
- Q69936626 description "artículu científicu espublizáu en xineru de 1985" @default.
- Q69936626 description "im Januar 1985 veröffentlichter wissenschaftlicher Artikel" @default.
- Q69936626 description "scientific article published on 01 January 1985" @default.
- Q69936626 description "wetenschappelijk artikel" @default.
- Q69936626 description "наукова стаття, опублікована в січні 1985" @default.
- Q69936626 name "A randomized comparison of cyclophosphamide, Adriamycin, and 5-fluorouracil with triethylenethiophosphoramide and methotrexate, both as sequential and as fixed rotational treatment in patients with advanced ovarian cancer" @default.
- Q69936626 name "A randomized comparison of cyclophosphamide, Adriamycin, and 5-fluorouracil with triethylenethiophosphoramide and methotrexate, both as sequential and as fixed rotational treatment in patients with advanced ovarian cancer" @default.
- Q69936626 name "A randomized comparison of cyclophosphamide, Adriamycin, and 5-fluorouracil with triethylenethiophosphoramide and methotrexate, both as sequential and as fixed rotational treatment in patients with advanced ovarian cancer" @default.
- Q69936626 type Item @default.
- Q69936626 label "A randomized comparison of cyclophosphamide, Adriamycin, and 5-fluorouracil with triethylenethiophosphoramide and methotrexate, both as sequential and as fixed rotational treatment in patients with advanced ovarian cancer" @default.
- Q69936626 label "A randomized comparison of cyclophosphamide, Adriamycin, and 5-fluorouracil with triethylenethiophosphoramide and methotrexate, both as sequential and as fixed rotational treatment in patients with advanced ovarian cancer" @default.
- Q69936626 label "A randomized comparison of cyclophosphamide, Adriamycin, and 5-fluorouracil with triethylenethiophosphoramide and methotrexate, both as sequential and as fixed rotational treatment in patients with advanced ovarian cancer" @default.
- Q69936626 prefLabel "A randomized comparison of cyclophosphamide, Adriamycin, and 5-fluorouracil with triethylenethiophosphoramide and methotrexate, both as sequential and as fixed rotational treatment in patients with advanced ovarian cancer" @default.
- Q69936626 prefLabel "A randomized comparison of cyclophosphamide, Adriamycin, and 5-fluorouracil with triethylenethiophosphoramide and methotrexate, both as sequential and as fixed rotational treatment in patients with advanced ovarian cancer" @default.
- Q69936626 prefLabel "A randomized comparison of cyclophosphamide, Adriamycin, and 5-fluorouracil with triethylenethiophosphoramide and methotrexate, both as sequential and as fixed rotational treatment in patients with advanced ovarian cancer" @default.
- Q69936626 P1433 Q69936626-71E863FF-A325-4D75-A678-503002EFF8DC @default.
- Q69936626 P1476 Q69936626-4750C5BF-CA45-4919-A2F6-7D6A5C7D4132 @default.
- Q69936626 P2093 Q69936626-237E7262-476F-4869-BF27-BF87E50A15EC @default.
- Q69936626 P2093 Q69936626-48D02538-107F-4008-A9D3-5DDCEC13B615 @default.
- Q69936626 P2093 Q69936626-74B44E52-BCC0-489F-B176-38FB139E2FA6 @default.
- Q69936626 P2093 Q69936626-89735F76-BB1E-4269-A05A-6D256BED0657 @default.
- Q69936626 P2093 Q69936626-8A98349E-B608-4D1C-A147-F8524AB8FABE @default.
- Q69936626 P2093 Q69936626-9212F20B-6B1E-4C2F-A121-68725D797981 @default.
- Q69936626 P2093 Q69936626-9E75C9FA-5283-4F14-8409-1F690EFE08F0 @default.
- Q69936626 P2093 Q69936626-A9E75473-7CC8-4A72-8E25-0BAA90CDAE13 @default.
- Q69936626 P2093 Q69936626-D339DA30-B1C1-4626-97C8-72C03D3BDB61 @default.
- Q69936626 P2093 Q69936626-DD87C932-4DFE-420D-AB3B-9C6BB5B3B220 @default.
- Q69936626 P304 Q69936626-1BC0A240-77FF-4D24-9C6E-082889AAE01B @default.
- Q69936626 P31 Q69936626-A751D0D7-0868-4766-ABA7-062AE695F5F3 @default.
- Q69936626 P356 Q69936626-2B3D6A50-C32D-44F6-92B5-9E6BBD594027 @default.
- Q69936626 P407 Q69936626-54AC3241-7796-4CFC-9536-D721DEC49650 @default.
- Q69936626 P433 Q69936626-218B2E6A-9338-414F-A861-D754432C7EA1 @default.
- Q69936626 P478 Q69936626-90A434E5-6847-443B-B637-2BFBE2FB11CC @default.
- Q69936626 P577 Q69936626-5CA05E40-C0BC-4978-A634-D17665E9E829 @default.
- Q69936626 P698 Q69936626-76A70792-A179-4550-8FCF-11CBEE18B332 @default.
- Q69936626 P921 Q69936626-2D06DF16-CC2D-4688-A3D9-6AB0279FE289 @default.
- Q69936626 P921 Q69936626-796FEDC6-6443-4B23-B61B-AD1BCAC9751A @default.
- Q69936626 P921 Q69936626-BA041623-02A4-4383-B67F-F3D54E5B771F @default.
- Q69936626 P921 Q69936626-DDC0A996-75F2-43FB-959E-16E41F17DD1C @default.
- Q69936626 P356 1097-0142(19850101)55:1%3C26::AID-CNCR2820550105%3E3.0.CO;2-D @default.
- Q69936626 P698 3917352 @default.
- Q69936626 P1433 Q326041 @default.
- Q69936626 P1476 "A randomized comparison of cyclophosphamide, Adriamycin, and 5-fluorouracil with triethylenethiophosphoramide and methotrexate, both as sequential and as fixed rotational treatment in patients with advanced ovarian cancer" @default.
- Q69936626 P2093 "E M Greenspan" @default.
- Q69936626 P2093 "G E Dinse" @default.
- Q69936626 P2093 "G Falkson" @default.
- Q69936626 P2093 "H S Brodovsky" @default.
- Q69936626 P2093 "H W Bruckner" @default.
- Q69936626 P2093 "J C Arseneau" @default.
- Q69936626 P2093 "M Pagano" @default.
- Q69936626 P2093 "R G Hahn" @default.
- Q69936626 P2093 "R H Creech" @default.
- Q69936626 P2093 "T E Davis" @default.
- Q69936626 P304 "26-40" @default.
- Q69936626 P31 Q13442814 @default.
- Q69936626 P356 "10.1002/1097-0142(19850101)55:1<26::AID-CNCR2820550105>3.0.CO;2-D" @default.
- Q69936626 P407 Q1860 @default.
- Q69936626 P433 "1" @default.
- Q69936626 P478 "55" @default.
- Q69936626 P577 "1985-01-01T00:00:00Z" @default.
- Q69936626 P698 "3917352" @default.
- Q69936626 P921 Q172341 @default.
- Q69936626 P921 Q18936 @default.
- Q69936626 P921 Q238512 @default.
- Q69936626 P921 Q422232 @default.